OrthoPediatrics Corp.

NASDAQ:KIDS

Medical - Devices

Healthcare
$31.65 +1.05%

+$0.19 today

Market cap
$826.40M
Beta
1.01
P/E (TTM)
-11.0
EPS (TTM)
-$1.68
52W Low $14.42High $23.70

Volume 0.16M

Average 0.16M

KIDS Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

OrthoPediatrics Corp.NASDAQ: KIDS

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin holds steady near 73.1%

Gross margin was 73.1% in Q1 FY2026, up 0.1 pp from a year earlier. On a trailing-twelve-month basis it was 73.1%, up 0.3 pp year over year. Over 3 fiscal years it narrowed by 1.1 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
73.1%-0.1 pp QoQ
Last fiscal yearDec 2025
73.1%+0.5 pp YoY
LTMMar 2026
73.1%+0.3 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+0.1 pp——
1 year+0.5 pp——
3 years-1.1 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
73.1%
Year-over-year change
+0.5pp

Gross Margin vs competitors

How KIDS compares with its peers on the latest reported figures

  • KIDS's LTM Mar 2026 gross margin of 73.1% is the 4th highest of the 8 companies compared; the peer median is 67.8%.
  • Its year-over-year change of +0.3 pp is the 4th highest of 8, against a peer median of +0.1 pp.
  • Over three fiscal years its change of -1.1 pp compares with a peer median of +4.5 pp.
KIDS Competitors Peer median
Gross Margin for KIDS and competitors
Company Period LTM level YoY 3-year change
CBLLCeriBell, Inc.LTM Mar 202687.7% +0.5 pp+5.0 pp
TMCITreace Medical Concepts, Inc.LTM Mar 202679.7% -0.5 pp-0.8 pp
RXSTRxSight, Inc.LTM Mar 202677.0% +9.7 pp+33.1 pp
KIDSOrthoPediatrics Corp.LTM Mar 202673.1% +0.3 pp-1.1 pp
BVSBioventus Inc.LTM Mar 202667.8% +0.6 pp+2.7 pp
EOLSEvolus, Inc.LTM Mar 202665.5% -2.3 pp+4.5 pp
LABStandard BioTools Inc.LTM Mar 202648.3% -1.2 pp+12.0 pp
TOIThe Oncology Institute, Inc.LTM Mar 202614.8% +0.1 pp-5.4 pp
Peer median (excluding KIDS) 67.8%+0.1 pp+4.5 pp

Competitors are the stored peer set for KIDS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue98.05M122.29M148.73M204.73M236.35M
Cost of Revenue24.65M31.63M37.48M56.13M63.69M
Gross Profit73.4M90.66M111.25M148.6M172.66M
Gross Margin74.9%74.1%74.8%72.6%73.1%
Research & Development5.54M8.45M10.9M11.03M9.1M
Selling, General & Admin85.73M104M126.12M167.09M192.56M
Operating Expenses91.43M116.06M138M178.12M201.66M
Depreciation & Amortization10.68M13.1M17.39M19.08M21.25M
EBITDA(7.19M)(8.69M)(8.38M)(20.23M)(11.94M)
EBITDA Margin-7.3%-7.1%-5.6%-9.9%-5.1%
Operating Income(18.02M)(25.4M)(26.75M)(29.52M)(29M)
Operating Margin-18.4%-20.8%-18.0%-14.4%-12.3%
Interest Income00198K00
Interest Expense2.25M2.42M02.62M6M
Other Income / Expenses636K21.71M5.44M(12.41M)(10.19M)
Income Before Tax(17.39M)(3.69M)(21.31M)(41.93M)(39.19M)
Pre-Tax Margin-17.7%-3.0%-14.3%-20.5%-16.6%
Income Tax Expense(1.13M)(4.95M)(338K)(4.11M)460K
Net Income(16.26M)1.26M(20.97M)(37.82M)(39.65M)
Net Margin-16.6%1.0%-14.1%-18.5%-16.8%
EPS (Basic)(0.84)0.06(0.92)(1.64)(1.69)
EPS (Diluted)(0.84)0.06(0.92)(1.64)(1.69)
Weighted Avg Shares19.27M20.7M22.68M23.08M23.46M
Weighted Avg Shares (Diluted)19.27M20.95M22.68M23.08M23.46M

OrthoPediatrics Corp.

NASDAQ:KIDS

Intrinsic Alpha fair value

Locked

Current Price

$31.65

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.